The exercise-app Axia for axial spondyloarthritis enhances the home-based exercise frequency in axial spondyloarthritis patients – A cross-sectional survey
Authors:
- Patrick-Pascal StrunzPSPatrick-Pascal Strunz
- Maxime Le MaireMMMaxime Le Maire
- Tobias HeusingerTHTobias Heusinger
- Juliana KleinJKJuliana Klein
- Hannah LabinskyHLHannah Labinsky
- Anna FleischerAFAnna Fleischer
- Karsten Sebastian LuetkensKLKarsten Sebastian Luetkens
- Patricia PosslerPPPatricia Possler
- Michael GernertMGMichael Gernert
- Robert LeppichRLRobert Leppich
- Astrid SchmiederASAstrid Schmieder
- Ludwig HammelLHLudwig Hammel
Open Access
- 29 April 2024
- journal article
- research article
- Published by Springer Nature in Rheumatology International
- Vol. 44 (6) , 1143-1154
Abstract
Background: Patients with axial spondyloarthritis (axSpA) benefit from regular home-based exercise (HbE). In spite of recommendations, a relevant proportion of German axSpA patients does not adhere to recommended HbE practices. To enhance HbE care, we developed the novel digital therapeutic (DTx) “Axia” compliant with the European medical device regulation (MDR). Axia offers a modern app-based HbE solution with patient educative content and further integrated features. Objective: We aimed to assess Axia’s efficacy, attractiveness, and functionality through a survey among axSpA-patients involved in the first user tests. Methods: A mixed-method online questionnaire with 38 items was administered to 37 axSpA volunteers after using Axia. Numeric rating scales (NRS) and likelihood scales were primarily used. Results: HbE frequency significantly increased from a median of 1 day/week to 6 days/week (p < 0.001) by using Axia. Existing HbE practitioners also increased their frequency (median of 4 days/week before, 6 days/week with Axia, p < 0.05). Axia received a median rating of 5 out of 5 stars. On NRS scales, Axia scored a median of 9 for intuitiveness and design, and a median of 8 for entertainment. 64.9% reported improved range of motion, 43.2% reported reduced pain, and 93.6% enhanced disease-specific knowledge. All users recommended Axia to other patients. Conclusion: Axia increases axSpA patients HbE frequency, possibly due to its good intuitiveness and design, leading to reduction in pain and subjective improvement of range of motion. This warrants further investigation in large randomized controlled interventional trials to establish its efficacy conclusively and patients adherence to HbE.Keywords
Funding Information
- Universitätsklinikum Würzburg
This publication has 23 references indexed in Scilit:
- Real-world usage of digital health applications (DiGA) in rheumatology: results from a German patient surveyRheumatology International, 2022
- Efficacy and safety of a mobile app intervention in patients with inflammatory arthritis: a prospective pilot studyRheumatology International, 2022
- Apps in rheumatologyZeitschrift für Rheumatologie, 2021
- Langfassung zur S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen, Update 2019Zeitschrift für Rheumatologie, 2019
- Maximizing Engagement in Mobile Health StudiesRheumatic Disease Clinics of North America, 2019
- Smartphone application for rheumatoid arthritis self-management: cross-sectional study revealed the usefulness, willingness to use and patients’ needsRheumatology International, 2015
- Home-based exercise therapy in ankylosing spondylitis: short-term prospective study in patients receiving tumor necrosis factor alpha inhibitorsRheumatology International, 2012
- Home-based exercise therapy in patients with ankylosing spondylitis: effects on pain, mobility, disease activity, quality of life, and respiratory functionsClinical Rheumatology, 2011
- Effects of a home-based exercise program on quality of life, fatigue, and depression in patients with ankylosing spondylitisRheumatology International, 2008
- Exercise and Changes in Health Status in Patients With Ankylosing SpondylitisArchives of internal medicine (1960), 2000